Hsp72-mediated augmentation of MHC class I surface expression and endogenous antigen presentation

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Efficient tumor cell recognition by cytolytic T lymphocytes (CTL) relies on MHC class I peptide presentation.
• Molecular chaperones can influence this crucial immune recognition process.
• B16 melanoma cells exhibit poor CTL recognition due to low surface MHC class I expression.

Purpose of the Study:

• To investigate the influence of molecular chaperones on MHC class I antigen presentation and CTL recognition in B16 melanoma.
• To determine if expressing human heat shock protein 72 (Hsp72) can enhance anti-tumor immunity.

Main Methods:

• Stable transfection of B16 melanoma cells with human Hsp72.
• Quantification of surface MHC class I antigen expression.
• Assessment of functional MHC-peptide complexes using conformation-dependent antibodies.
• Evaluation of CTL recognition and tumor resistance in vivo.
• Analysis of transporter associated with antigen presentation (TAP) function.

Main Results:

• B16 cells expressing Hsp72 showed significantly increased surface MHC class I antigen levels.
• Hsp72 expression led to enhanced functional MHC-peptide complexes and improved CTL recognition.
• Hsp72 did not rescue the antigen presentation defect in TAP-deficient cells.
• Mice immunized with Hsp72-expressing B16 cells exhibited increased resistance to wild-type B16 tumor challenge.

Conclusions:

• Constitutive expression of the molecular chaperone Hsp72 enhances the immune recognition of B16 melanoma cells.
• Hsp72 up-regulates surface MHC class I antigen presentation, leading to improved anti-tumor immunity.
• Targeted expression of molecular chaperones represents a potential strategy for enhancing cancer immunotherapy.